 This is a randomized, double blinded , controlled, two-center study assessing the feasibility, efficacy and safety of intravitreal ranibizumab injection applied as a preoperative adjunct treatment before vitrectomy surgery in severe proliferative diabetic retinopathy PDR. Comparator arm consists of patients receiving standard vitrectomy alone with sham intravitreal injection preoperatively. 